Back
RxSight 10K Form
Sell
10
RXST
RxSight
Last Price:
$33.34
Seasonality Move:
25.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RXST News And Ratings
See the #1 stock for the next 7 days that we like better than RXST
RXST Financial Statistics
Sales & Book Value
| Annual Sales: | $89.1M |
|---|---|
| Cash Flow: | $-453K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.89 |
| Price / Book: | 4.97 |
Profitability
| EPS (TTM): | -0.82000 |
|---|---|
| Net Income (TTM): | $-30.7M |
| Gross Margin: | $53.8M |
| Return on Equity: | -14.78% |
| Return on Assets: | -13.19% |
RxSight Earnings Forecast
Key RxSight Financial Ratios
-
The Gross Profit Margin over the past 5 years for RXST is 60.36%.
-
The Selling, General & Administrative Expenses for RXST have been equal to 83.97% of Gross Profit Margin.
-
The Research & Development expenses have been 32.61% of Revenue.
-
The Interest Expense is -6.81% of Operating Income.
-
The Net Earning history of RXST is -54.57% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 2 years.
RxSight Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | RXST |
| Website: | rxsight.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.67 |
| Quick Ratio: | 11.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 192.49 |